Could cause temporary or reversible harm; serious harm is unlikely.
Lack of Sterility Assurance
| Distributed by / for | Somerset Therapeutics, LLC., Somerset, NJ 08873 |
| NDC | 70069-0857-01 |
| Full product label | Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and Intravenous Use, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0857-01 |
| Recalling firm | Reliance Life Sciences Private Limited |
| Distribution | Nationwide in the USA |
| Quantity | 8,001 vials |
| Recall initiated | 2026-06-24 |
| Report date | 2026-07-15 |
| Recall completed | — |
| Recall number | D-0674-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Navi Mumbai N/A India |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗